Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter

Michael Lim, Michael Weller, Ahmed Idbaih, Joachim Steinbach, Gaetano Finocchiaro, Raju R. Raval, George Ansstas, Joachim Baehring, Jennie W. Taylor, Jerome Honnorat, Kevin Petrecca, Filip De Vos, Antje Wick, Ashley Sumrall, Solmaz Sahebjam, Ingo K. Mellinghoff, Masashi Kinoshita, Mustimbo Roberts, Ruta Slepetis, Deepti WaradDavid Leung, Michelle Lee, David A. Reardon, Antonio Omuro

Research output: Contribution to journalArticlepeer-review

257 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience